Folate metabolic pathways in Leishmania.
Trypanosomatid parasitic protozoans of the genus Leishmania are autotrophic for both folate and unconjugated pteridines. Leishmania salvage these metabolites from their mammalian hosts and insect vectors through multiple transporters. Within the parasite, folates are reduced by a bifunctional DHFR (dihydrofolate reductase)-TS (thymidylate synthase) and by a novel PTR1 (pteridine reductase 1), which reduces both folates and unconjugated pteridines. PTR1 can act as a metabolic bypass of DHFR inhibition, reducing the effectiveness of existing antifolate drugs. Leishmania possess a reduced set of folate-dependent metabolic reactions and can salvage many of the key products of folate metabolism from their hosts. For example, they lack purine synthesis, which normally requires 10-formyltetrahydrofolate, and instead rely on a network of purine salvage enzymes. Leishmania elaborate at least three pathways for the synthesis of the key metabolite 5,10-methylene-tetrahydrofolate, required for the synthesis of thymidylate, and for 10-formyltetrahydrofolate, whose presumptive function is for methionyl-tRNAMet formylation required for mitochondrial protein synthesis. Genetic studies have shown that the synthesis of methionine using 5-methyltetrahydrofolate is dispensable, as is the activity of the glycine cleavage complex, probably due to redundancy with serine hydroxymethyltransferase. Although not always essential, the loss of several folate metabolic enzymes results in attenuation or loss of virulence in animal models, and a null DHFR-TS mutant has been used to induce protective immunity. The folate metabolic pathway provides numerous opportunities for targeted chemotherapy, with strong potential for 'repurposing' of compounds developed originally for treatment of human cancers or other infectious agents.
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Tim J
TJ
Vickers
Stephen M
SM
Beverley
D000594:Amino Acid Oxidoreductases / Q000378:metabolism; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D005492:Folic Acid / Q000378:metabolism*; D006790:Host-Parasite Interactions; D007506:Iron-Sulfur Proteins / Q000378:metabolism; D007891:Leishmania / Q000235:genetics / Q000378:metabolism*; D053858:Metabolic Networks and Pathways; D008715:Methionine / Q000378:metabolism; D009097:Multienzyme Complexes / Q000378:metabolism; D011621:Pteridines / Q000378:metabolism; D011687:Purines / Q000378:metabolism; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D013763:Tetrahydrofolates / Q000378:metabolism; D013940:Thymidylate Synthase / Q000235:genetics / Q000378:metabolism; D014166:Transferases / Q000378:metabolism
D002352:Carrier Proteins; D007506:Iron-Sulfur Proteins; D009097:Multienzyme Complexes; D011621:Pteridines; D011687:Purines; D013763:Tetrahydrofolates; C064525:glycine cleavage system; C013123:5,10-methylenetetrahydrofolic acid; D005492:Folic Acid; D008715:Methionine; D000594:Amino Acid Oxidoreductases; D013762:Tetrahydrofolate Dehydrogenase; D014166:Transferases; D013940:Thymidylate Synthase; C005984:5-methyltetrahydrofolate